Apo B is a key marker for circulating atherogenic lipoproteins, offering a more precise indicator of cardiovascular risk than traditional cholesterol measures.[37–40] Our findings revealed a significant reduction in Apo B levels in the CREP group, indicating improved lipid metabolism and a reduced risk of cardiovascular disease. The gene discussed is APOB; the disease is cardiovascular disorder.